Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 09/25 10:39:44 am
53.345 EUR   -1.96%
03:19aBAYER : resolves more Roundup cases, judge keeps pause on litigation
RE
09/24BAYER : resolves more Roundup cases, judge keeps pause on litigation
RE
09/21BAYER : opens application window for Grants4Ag
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

BAYER AG : Receives a Buy rating from Goldman Sachs

share with twitter share with LinkedIn share with facebook
08/12/2020 | 12:58am EDT

In a research note published by Keyur Parekh, Goldman Sachs advises its customers to buy the stock. The target price is being increased from EUR 74 to EUR 84.

Stocks mentioned in the article
ChangeLast1st jan.
BAYER AG -1.97% 53.29 Delayed Quote.-25.27%
THE GOLDMAN SACHS GROUP, INC. -1.76% 191.5549 Delayed Quote.-15.14%

© MarketScreener with dpa-AFX Analyser 2020
share with twitter share with LinkedIn share with facebook
All news about BAYER AG
03:19aBAYER : resolves more Roundup cases, judge keeps pause on litigation
RE
09/24BAYER : resolves more Roundup cases, judge keeps pause on litigation
RE
09/21BAYER : opens application window for Grants4Ag
PU
09/18GLOBAL MARKETS LIVE : Tiktok, CaixaBank, Moderna…
09/18Covestro denies it is in takeover talks with Apollo
RE
09/17EXCLUSIVE : In the weeds - How Bayer, U.S. government teamed up against Thailand..
RE
09/17IN THE WEEDS : How Bayer, U.S. govt teamed up against Thailand's glyphosate ban
RE
09/17BAYER : New data reinforce strong clinical profile of Vitrakvi™ for patien..
PU
09/15BAYER : settles thousands of U.S. Roundup cases with trial attorneys
RE
09/15Bayer settles thousands of U.S. Roundup cases with trial attorneys
RE
More news
Financials
Sales 2020 43 305 M 50 399 M 50 399 M
Net income 2020 -2 690 M -3 131 M -3 131 M
Net Debt 2020 32 651 M 38 000 M 38 000 M
P/E ratio 2020 -16,2x
Yield 2020 5,22%
Capitalization 53 454 M 62 264 M 62 209 M
EV / Sales 2020 1,99x
EV / Sales 2021 1,91x
Nbr of Employees 101 168
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 78,72 €
Last Close Price 54,41 €
Spread / Highest target 102%
Spread / Average Target 44,7%
Spread / Lowest Target -15,5%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Norbert Winkeljohann Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-25.27%62 264
JOHNSON & JOHNSON-0.82%380 891
ROCHE HOLDING AG5.67%305 409
MERCK & CO., INC.-8.58%210 306
PFIZER, INC.-8.12%198 714
NOVARTIS AG-12.73%190 455